AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Celgene
John P Leonard; Marek Trneny; Koji Izutsu; Nathan H Fowler; Xiaonan Hong; Jun Zhu; Huilai Zhang; Fritz Offner; Adriana Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian W Flinn; Claudia Moreira; José Cabeçadas; David Liu; Stacey Kalambakas; Pierre Fustier; Chengqing Wu; John G Gribben